[Boston.com] Top executives of the state’s two largest biotechnology companies offered diverging views today on the health care bill signed into law by President Obama, with one contending it protects innovation and the other insisting it does little to control costs. “I don’t think this health care reform really addresses the fundamental underlying issues that [...]